|
2025 |
Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care
|
Salas MQ |
Salas MQ, Solano MT, Baile Gonzalez M, Acera Gomez M, Fox L, Perez Artigas MM, Santamaría A, Quintela Gonzalez MC, Sanchez Salinas A, Salmeron Camacho JM, Illana Alvaro V, Abdallahi-Lefdil Z, Cornago Navascues J, Pardo L, Fernandez-Luis S, Vega Suarez LP, Villar S, Beorlegui-Murillo P, Esquirol A, Izquierdo Garcia I, Rodriguez Gonzalez S, Mussetti A, Lavilla E, Lopez-Marin J, Filaferro S, Cedillo A, Bento L and Sureda A |
Front. Immunol. 15:1512154. doi: 10.3389/fimmu.2024.1512154 |
5.7 |
Ver artículo
|
|
2024 |
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.
|
Escamilla-Gómez V |
Escamilla-Gómez V, García Gutiérrez V, Alcalde-Mellado P, Astibia-Mahillo B, Chinea-Rodriguez A, López-Corral L, Acera-Gómez M, Torres Ochando MK, Borrero Borrego A, González Pinedo L, Zudaire Ripa T, González Vicent M, Benzaquén A, Izquierdo Garcia I, Asensi Cantó P, Montoro J, Martín-Domínguez FM, Orti G, Valcárcel D, Benitez-Carabante MI, Diaz-de-Heredia C, Cañamero E, Ferrá C, García-Cadenas I, Redondo S, Sisinni L, Perez-Martínez A, Mussetti A, Garcia-Mañó L, Palomo-Moraleda MDP, González-Sierra PA, Jurado M, Perez-Simon JA |
Bone Marrow Transplant. 2024 Dec 11. doi: 10.1038/s41409-024-02483-0. Online ahead of print.PMID: 39663471 |
4.5 |
Ver artículo
|
|
2024 |
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee
|
M González Vicent |
B Molina, M Panesso, D Bueno, A Pascual 5, S Vinagre, Y Mozo, J L Fuster, R Olivas, C Fuentes, M López, A Regueiro, P Palomo, C Díaz de Heredia |
Cytotherapy |
3.7 |
Ver artículo
|
|
2024 |
Successful allogeneic CD34(+) hematopoietic stem cell boost for prolonged cytopenias following CAR T-cell therapy in B-cell acute lymphoblastic leukemia. On behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
|
Molinos-Quintana Á |
Molinos-Quintana Á, Martínez-Cibrian N, Alonso-Saladrigues A, Galán-Gómez V, Bailén R, Buendía-López S, Fuentes-Socorro C, Kwon M, González-Vincent M, Pérez de Soto C, González-Martínez B, Rives S, Pérez-Hurtado JM, Ortiz-Maldonado V, Pérez-Simón JA. |
Bone Marrow Transplant. 2024 Nov 17. doi: 10.1038/s41409-024-02473-2. Online ahead of print.PMID: 39551836 |
4.5 |
Ver artículo
|
|
2024 |
Targeting Hedgehog Signaling with Glasdegib in Patients with Refractory Sclerotic Chronic GVHD: A Report of Two Phase I/II Trials
|
Rodríguez-Arbolí E |
Rodríguez-Arbolí E, Lee CJ, Caballero-Velázquez T, Martínez C, García-Calderón C, Jiménez-León MR, Bermúdez-Rodríguez MA, López-Corral L, Triguero A, Onstad L, Horwitz ME, Sarantopoulos S, Lee SJ, Pérez-Simón JA |
Clin Cancer Res. 2023 Oct 13;29(20):4057-4067. doi: 10.1158/1078-0432.CCR-23-0666. PMID: 37698881. |
11.5 |
Ver artículo
|
|
2024 |
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients
|
Mingot-Castellano ME |
Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, López-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martín A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simón JA, Sánchez-Pina JM, On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Geth-Tc |
J Clin Med. 2024 Aug 28;13(17):5117. doi: 10.3390/jcm13175117. PMID: 39274330; PMCID: PMC11396136 |
4.96 |
Ver artículo
|
|
2024 |
Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.
|
Salas MQ |
Salas MQ, Cascos E, López-García A, Pérez-López E, Baile-González M, López-Corral L, Pascual Cascón MJ, Luque M, Esquirol A, Heras Fernando I, Oiartzabal Ormtegi I, Sáez Marín AJ, Peña-Muñóz F, Fernández-Luis S, Domínguez-García JJ, Villar Fernández S, Fernández de Sanmamed Girón M, González Pinedo L, González-Rodríguez AP, Torrado T, García L, Filaferro S, Cedillo Á, Basalobre P, Ortí G, Jurado Chacón M. |
Bone Marrow Transplant. 2024 Dec;59(12):1694-1703. doi: 10.1038/s41409-024-02414-z. Epub 2024 Sep 14.PMID: 39277653 |
4.5 |
Ver artículo
|
|
2024 |
Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood. A study of the Spanish Pediatric Group for Hematopoietic Cell Transplantation and Cell Therapy (GETH-TC)
|
Uria-Oficialdegui ML |
Uria-Oficialdegui ML, Quintero V, Benitez-Carabante MI, Bueno D, Trabazo M, Lopez-Duarte M, Alonso L, Panesso M, Murillo-Sanjuan L, Fuentes C, Gomez G, Gonzalez-Vicent M, Verdu J, Diaz-de-Heredia C |
Bone Marrow Transplant. 2024 Sep 3. doi: 10.1038/s41409-024-02406-z. Epub ahead of print. PMID: 39227649 |
4.5 |
Ver artículo
|
|
2024 |
Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC).
|
Piñana JL |
Piñana JL, Giménez E, Vázquez L, Marcos MÁ, Guerreiro M, Duarte R, Pérez A, de Miguel C, Espigado I, González-Vicent M, Suarez-Lledó M, García-Cadenas I, Martino R, Cedillo A, Rovira M, de la Cámara R, Navarro D, Solano C. |
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES |
2 |
Ver artículo
|
|
2024 |
Cardiac Events after Allo-HCT in Patients with Acute Myeloid Leukemia. Study Conducted con Behalf of the GETH-TC.
|
Salas MQ |
Salas MQ, Cascos E, Lopez-Garcia A, Pérez López E, Baile M, Martín-Rodriguez C, Pascual-Cascón MJ, Luque Garrido M, Esquirol A, Heras I, Peña-Muñóz F, Oiartzabal Ormategi I, Sáez-Marín AJ, Fernández-Luis S, Dominguez-Garcia JJ, Villar S, Fernández de Sanmamed Girón M, González-Pinedo L, Garcia-Maño L, Gonzalez-Rodriguez AP, Torrado Chedas T, Filafferro S, Cedillo A, Ortí G, Jurado M |
Blood Adv. 2024 Aug 23:bloodadvances.2024013535. doi: 10.1182/bloodadvances.2024013535. Epub ahead of print. PMID: 39178345 |
7.4 |
Ver artículo
|
|
2024 |
Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético)
|
Sisinni L |
Sisinni L, Monserrate GXA, Hurtado JMP, Panesso M, Molina B, Fuentes C, Fuster JL, Verdu-Amoros J, Regueiro A, Palomo P, Beléndez C, Pascual A, Badell I, Mozo Y, Bueno D, Pérez-Martínez A, Fernández JM, Vicent MG, de Heredia CD |
Transplant Cell Ther. 2024 Jul 25:S2666-6367(24)00544-X. doi: 10.1016/j.jtct.2024.07.013. Epub ahead of print. PMID: 39067788 |
3.6 |
Ver artículo
|
|
2024 |
Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies.
|
Fox ML |
Fox ML, García-Cadenas I, Navarro V, Martínez AP, Kara M, Bazán IS, Ferra Coll C, Bailén R, Bento L, Parody R, Esquirol A, Ortí G, Mussetti A, Salamero O, Martino R, González AP, Barba P, Kwon M, Solano C, Bosch F, Valcárcel D; Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). |
Bone Marrow Transplant. 2024 Jun 24. doi: 10.1038/s41409-024-02322-2. Epub ahead of print. PMID: 38914883 |
4.5 |
Ver artículo
|
|
2024 |
Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GETH
|
Bailén R |
Bailén R, Iacoboni G, Delgado J, López-Corral L, Hernani-Morales R, Ortiz-Maldonado V, Guerreiro M, Caballero AC, Guerra-Domínguez ML, Sánchez-Pina JM, Peña M, Torrent A, Pérez-Martínez A, Bastos-Oreiro M, Reguera-Ortega JL, Martín A, Hernandez-Boluda JC, Martínez-Cibrián N, Sanz J, Briones J, Henriquez HL, Calbacho M, Mussetti A, Sancho JM, Barba P, Kwon M; GETH-TC (Spanish Group of Stem Cell Transplantation and Cell Therapy) and GETH (Spanish Group of Lymphoma and Autologous Stem Cell Transplantation). |
Transplant Cell Ther. 2024 Jul 26:S2666-6367(24)00485-8. doi: 10.1016/j.jtct.2024.06.022. Epub ahead of print. PMID: 39069076 |
3.6 |
Ver artículo
|
|
2024 |
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
|
Piñana JL |
Piñana JL, Vazquez L, Heras I, Aiello TF, Lopez-Corral L, Arroyo I, Soler-Espejo E, Garc?a-Cadenas I, Garcia-Gutierrez V, Aroca C, Chorao P, Olave MT, Lopez-Jimenez J, Gomez MA, Arellano E, Cuesta-Casas M, Avendaño-Pita A, Gonzalez-Santillana C, Hernandez-Rivas JA, Roldan-Perez A, Mico-Cerda M, Guerreiro M, Morell J, Rodriguez-Galvez P, Labrador J, Campos D, Cedillo A, Vidal CG, Martino R and Solano C |
Front. Oncol. 14:1389345. doi: 10.3389/fonc.2024.1389345 |
3.5 |
Ver artículo
|
|
2024 |
REAL-WORLD EXPERIENCE OF ISAVUCONAZOLE IN ALLOGENEIC STEM CELL TRANSPLANTATION IN SPAIN
|
Kwon M |
Kwon M, Gómez-Centurión I, Oarbeascoa G, Torres M, Martinez AP, Suarez-Lledó M, Chinea A, Cascón MJP, Vazquez L, Espigado I, Izquierdo I, Parody R, Cadenas IG, Calbacho M, Sierra PG, Heras I, Yañez L, Torrent A, Bautista G, Gonzalez S, Roldan E, Vallejo JC, Bailen R, Borrero A, Lopez-Jiménez J, Casas MAC, Solano C; on behalf of the Spanish Group of Hematopoietic Stem Cell Transplantation and Cell Therapy (GETH-TC) |
Transplant Cell Ther. 2024 Jun 11:S2666-6367(24)00467-6. doi: 10.1016/j.jtct.2024.06.009. Epub ahead of print. PMID: 38871055. |
3.2 |
Ver artículo
|
|
2024 |
SINUSOIDAL OBSTRUCTION SYNDROME/VENO-OCCLUSIVE DISEASE AFTER UNMANIPULATED HAPLOIDENTICAL HSCT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE: A STUDY ON BEHALF OF THE SPANISH HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELLULAR THERAPY GROUP (GETH)
|
Gómez-Centurión I |
Gómez-Centurión I, Gallardo Morillo AI, Pérez Martínez A, Cabrero Calvo M, Chinea A, González L, Pedraza A, Jiménez Lorenzo MJ, Robles MC, Bailén R, Cascón MJP, Cabero A, Piñana Sánchez JL, Luna A, Perera Alvarez M, Rovira M, Torrent Catarineu A, Sánchez-Pina J, Kwon M |
Transplant Cell Ther. 2024 Jun 6:S2666-6367(24)00440-8. doi: 10.1016/j.jtct.2024.06.003. Epub ahead of print. PMID: 38851323 |
3.2 |
Ver artículo
|
|
2024 |
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia
|
Mora E |
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Español de Trasplante Hematopoyético (GETH) |
Bone Marrow Transplant. 2024 May 16. doi: 10.1038/s41409-024-02298-z. Epub ahead of print. PMID: 38755458 |
5.48 |
Ver artículo
|
|
2024 |
Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC
|
Fonseca-Santos M |
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, García-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortés-Rodriguez M, Yañez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Español de Trasplante Hematopoyético y Terapia Celular |
Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000005034. Epub ahead of print. PMID: 38685204 |
6.2 |
Ver artículo
|
|
2024 |
Use of eculizumab in pediatric patients with high-risk transplant-associated thrombotic microangiopathy: outcomes and risk factors associated with response and survival. A retrospective study on behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
|
Benítez-Carabante MI |
Benítez-Carabante MI, Bueno D, Alonso García L, López Torija I, Marsal J, Fernandez NavarroJM, Uria Oficialdegui ML, Panesso M, Molina B, Beléndez Bieler C, Palomo P, Pérez Martínez A, Diaz-de-Heredia C |
Transplant Cell Ther. 2024 Mar 21:S2666-6367(24)00292-6. doi: 10.1016/j.jtct.2024.03.019. Epub ahead of print. PMID: 38521410. |
3.2 |
Ver artículo
|
|
2024 |
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial
|
Cabrero M |
Cabrero M, López-Corral L, Jarque I, de la Cruz-Vicente F, Pérez-López E, Valcárcel D, Sanz J, Espigado I, Ortí G, Martín-Calvo C, de la Serna J, Caballero D; Grupo Español de Trasplante Hematopoyético (GETH) and Grupo Español de Linfomas y Trasplante Autólogo (GETH) |
Bone Marrow Transplant. 2024 Mar;59(3):359-365. doi: 10.1038/s41409-023-02171-5. Epub 2024 Jan 2. PMID: 38167647. |
4.8 |
Ver artículo
|
